Table 1 Total and differential cell count in BALf from patients with interstitial lung diseases
From: Endotoxin markers in bronchoalveolar lavage fluid of patients with interstitial lung diseases
TCC [x106] | AM [%] | L [%] | PMN [%] | Eo [%] | |
|---|---|---|---|---|---|
sarcoidosis n= 22 | 19 (12–25) | 47 (33–60) | 36 (24–56) | 6 (4–11) | 0.6 (0–2) |
lung fibrosis n=42 | 29 (18–40) | 48 (30–81) | 15 (2–33) | 10 (5–25) | 4 (1–14) |
sr-ILD1n=11 | 59 (30–68) | 93 (90–94) | 2 (1–4) | 2 (1.5-3) | 2 (1–6) |
eosinophilic disorders n=8 | 22 (13–31) | 13.5 (7.5-45) | 6 (1.5-8.75) | 8 (3.25-17) | 51 (37–82) |